441 results AFM's spotlight on substantial holding notifications In its latest market watch, the AFM places a spotlight on notifications of substantial holdings and gross short positions in response to the ongoing public discourse on the issue. Settlement procedure and fine for vertical price fixing in Belgium The Belgian Competition Authority imposed a fine of €490,112 on Le Creuset for vertical price fixing (also known as resale price maintenance). On repeat but louder: the ACM’s 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACM’s priority list, but now with better-equipped enforcement methods available. Stibbe advises PAG-ASA Over the past years, Stibbe has collaborated with PAG-ASA by providing pro bono legal aid to victims and representing them before the criminal courts. Stibbe advises Dierenartsen zonder grenzen / Vétérinaires sans Frontières Belgium Stibbe has assisted Dierenartsen Zonder Grenzen / Vétérinaires Sans Frontières Belgium with pro bono legal advice regarding GDPR compliance. Stibbe advises ArmenTekort Stibbe has advised ArmenTekort on data processing and GDPR compliance. Stibbe advises the underwriters on the capital increase of WDP Stibbe advised the underwriters on WDP's successful EUR 300 million capital increase by means of an accelerated book building. Stibbe advises the underwriters on the capital increase of Xior Stibbe advised the underwriters on the successful capital increase of Xior by means of an accelerated bookbuilding (ABB), resulting in gross proceeds of EUR 75,7 million. Developments in green bonds: On 21 December 2024 the EU Green Bond Regulation starts to apply In this blog, Marieke Driessen and Niek Groenendijk of our Financial Markets team discuss the EU green bonds regulation which will start applying in 2024. Stibbe appoints two new counsel in Brussels We are pleased to announce that the Brussels office of Stibbe has appointed Tobe Inghelbrecht (Litigation & Arbitration) and Renaud Smal (Environment & Planning) as Counsel, effective 1 January 2024. Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor. Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy. Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies. Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ. The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief. Pagination Previous page Page 2 Current page 3 Page 4 Page 5 Next page
AFM's spotlight on substantial holding notifications In its latest market watch, the AFM places a spotlight on notifications of substantial holdings and gross short positions in response to the ongoing public discourse on the issue.
Settlement procedure and fine for vertical price fixing in Belgium The Belgian Competition Authority imposed a fine of €490,112 on Le Creuset for vertical price fixing (also known as resale price maintenance).
On repeat but louder: the ACM’s 2024 priorities On 23 January 2024, the ACM announced its priorities for 2024. The energy transition, the digital economy and sustainability are still on the ACM’s priority list, but now with better-equipped enforcement methods available.
Stibbe advises PAG-ASA Over the past years, Stibbe has collaborated with PAG-ASA by providing pro bono legal aid to victims and representing them before the criminal courts.
Stibbe advises Dierenartsen zonder grenzen / Vétérinaires sans Frontières Belgium Stibbe has assisted Dierenartsen Zonder Grenzen / Vétérinaires Sans Frontières Belgium with pro bono legal advice regarding GDPR compliance.
Stibbe advises the underwriters on the capital increase of WDP Stibbe advised the underwriters on WDP's successful EUR 300 million capital increase by means of an accelerated book building.
Stibbe advises the underwriters on the capital increase of Xior Stibbe advised the underwriters on the successful capital increase of Xior by means of an accelerated bookbuilding (ABB), resulting in gross proceeds of EUR 75,7 million.
Developments in green bonds: On 21 December 2024 the EU Green Bond Regulation starts to apply In this blog, Marieke Driessen and Niek Groenendijk of our Financial Markets team discuss the EU green bonds regulation which will start applying in 2024.
Stibbe appoints two new counsel in Brussels We are pleased to announce that the Brussels office of Stibbe has appointed Tobe Inghelbrecht (Litigation & Arbitration) and Renaud Smal (Environment & Planning) as Counsel, effective 1 January 2024.
Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor.
Stibbe advises GRW on the acquisition of Van Hool’s industrial vehicle division Stibbe advised GRW, the South African tanker and trailer manufacturer allied with Schmitz Cargobull, on acquiring the industrial vehicle division of Van Hool, following the latter’s declaration of bankruptcy.
Stibbe advises Goed A multidisciplinary Stibbe team advised Goed and its shareholders on its binding agreement with Mulitpharma relating to the sale of Goed’s pharmaceutical retail and wholesale business.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The Foreign Subsidies Regulation’s initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commission’s initial enforcement actions appear to be targeting Chinese subsidies.
Stibbe advises the SCHMID Group Stibbe, together with Gleiss Lutz, has advised the SCHMID Group on its business combination with Pegasus Digital Mobility Acquisition Corp. and listing on NASDAQ.
The honeymoon phase of the Foreign Subsidies Regulation is over! Paperwork, paperwork, paperwork. The industry voices have been clear about the Foreign Subsidies Regulation. But what is the authority’s view? We provide an update on recent developments, including the European Commission’s first policy brief.